![](/img/cover-not-exists.png)
Novel interaction mechanism of a domain antibody based inhibitor of human vascular endothelial growth factor with greater potency than ranibizumab and bevacizumab and improved capacity over aflibercept.
Walker, Adam, Chung, Chun-wa, Neu, Margaret, Burman, Manish, Batuwangala, Thil, Jones, Gavin, Tang, Chi-Man, Steward, Michael, Mullin, Michael, Tournier, Nadia, Lewis, Alan, Korczynska, Justyna, ChungLanguage:
english
Journal:
Journal of Biological Chemistry
DOI:
10.1074/jbc.M115.691162
Date:
January, 2016
File:
PDF, 2.09 MB
english, 2016